Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma
Autor: | Joseph W. Carlson, Marike Gabrielson, Maria C. Shoshan, My Björklund |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
endocrine system diseases
Cell lcsh:Medicine Mitochondrion Bioinformatics Biochemistry Molecular Cell Biology Basic Cancer Research Medicine and Health Sciences Cystadenocarcinoma lcsh:Science Aged 80 and over Ovarian Neoplasms Multidisciplinary Obstetrics and Gynecology Middle Aged Prognosis Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha female genital diseases and pregnancy complications DNA-Binding Proteins Serous fluid medicine.anatomical_structure Oncology Cytochemistry Disease Progression Adenocarcinoma Female Glycogen Research Article Signal Transduction Adult Biology Mitochondrial Proteins Cell Line Tumor medicine Carcinoma Cancer Detection and Diagnosis Biomarkers Tumor Humans Aged lcsh:R Gynecologic Cancers Biology and Life Sciences Cell Biology TFAM medicine.disease Cystadenocarcinoma Serous Drug Resistance Neoplasm Cancer research Women's Health lcsh:Q Ovarian cancer Adenocarcinoma Clear Cell Transcription Factors |
Zdroj: | PLoS ONE, Vol 9, Iss 9, p e107109 (2014) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Epithelial ovarian carcinoma (EOC), the major cause of gynaecological cancer death, is a heterogeneous disease classified into five subtypes. Each subtype has distinct clinical characteristics and is associated with different genetic risk factors and molecular events, but all are treated with surgery and platinum/taxane regimes. Tumour progression and chemoresistance is generally associated with major metabolic alterations, notably altered mitochondrial function(s). Here, we report for the first time that the expression of the mitochondrial regulators PGC1α and TFAM varies between EOC subtypes; furthermore, we have identified a profile in clear-cell carcinoma consisting of undetectability of PGC1α/TFAM, and low ERα/Ki-67. By contrast, high-grade serous carcinomas were characterised by a converse state of PGC1α/TFAM, ERα positivity and a high Ki-67 index. Interestingly, loss of PGC1α/TFAM and ERα was found also in a non-clear cell EOC cell line made highly resistant to platinum in vitro. Similar to clear-cell carcinomas, these resistant cells also showed accumulation of glycogen. Altogether, our data provide mechanistic insights into the chemoresistant nature of ovarian clear-cell carcinomas. Furthermore, these findings corroborate the need to take into account the diversity of EOC and to develop subtype specific treatment strategies. |
Databáze: | OpenAIRE |
Externí odkaz: |